| Dr Kenneth M Crandall, MD | |
|
7505 Osler Dr Ste 104, Towson, MD 21204-7737 | |
| (410) 337-8888 | |
| (410) 823-4833 |
| Full Name | Dr Kenneth M Crandall |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | 7505 Osler Dr Ste 104, Towson, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447485891 | NPI | - | NPPES |
| D0083337 | Other | MD | MARYLAND LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | D0083337 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Of Maryland | Baltimore, MD | Home health agency |
| Home Call, Inc | Westminster, MD | Home health agency |
| University Of Maryland Medical Center | Baltimore, MD | Hospital |
| University Of Md St Joseph Medical Center | Towson, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Maryland St Joseph Medical Group Llc | 4880846179 | 224 |
| University Of Maryland Neurosurgery Associates P A | 9133187750 | 18 |
News Archive
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease.
According to a new study eating out does not necessarily have to mean consuming large portions of high-calorie foods and becoming obese.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
› Verified 6 days ago
| Entity Name | Shock Trauma Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679512909 PECOS PAC ID: 6800882317 Enrollment ID: O20040421000976 |
News Archive
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease.
According to a new study eating out does not necessarily have to mean consuming large portions of high-calorie foods and becoming obese.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
› Verified 6 days ago
| Entity Name | University Of Maryland Neurosurgery Associates P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639119035 PECOS PAC ID: 9133187750 Enrollment ID: O20041229000741 |
News Archive
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease.
According to a new study eating out does not necessarily have to mean consuming large portions of high-calorie foods and becoming obese.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
› Verified 6 days ago
| Entity Name | University Of Maryland St Joseph Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770836785 PECOS PAC ID: 4880846179 Enrollment ID: O20121213000234 |
News Archive
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease.
According to a new study eating out does not necessarily have to mean consuming large portions of high-calorie foods and becoming obese.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
› Verified 6 days ago
| Entity Name | University Of Maryland St. Joseph Orthopaedics, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982950846 PECOS PAC ID: 0941455794 Enrollment ID: O20130227000318 |
News Archive
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease.
According to a new study eating out does not necessarily have to mean consuming large portions of high-calorie foods and becoming obese.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth M Crandall, MD 8322 Bellona Ave Ste 100, Towson, MD 21204-2065 Ph: (410) 337-7900 | Dr Kenneth M Crandall, MD 7505 Osler Dr Ste 104, Towson, MD 21204-7737 Ph: (410) 337-8888 |
News Archive
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease.
According to a new study eating out does not necessarily have to mean consuming large portions of high-calorie foods and becoming obese.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
› Verified 6 days ago
Dr. Bernhard Zunkeler, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1122 Kenilworth Dr Ste 116, Towson, MD 21204 Phone: 410-337-8201 Fax: 410-500-4567 |